If you need more lookups,
subscriptions start at $34 USD/month.
Marco Passini Location
Cambridge, MA, US
Marco Passini Work
2024 -now Biotechnology Consultant @ Expertise in Gene and Oligonucleotide Therapies for CNS and Muscle Disorders
2022 -2024 Vice President, Head of CNS Biology @
2020 -2022 Senior Director, Pharmacology @ Disarm Therapeutics, a wholly owned subsidiary of Eli Lilly
2014 -2019 Senior Director and Director Biology @
2002 -2014 Scientist, Rare Diseases Science @ Genzyme Corporation, a Sanofi Company
Marco Passini Education
University of Pennsylvania
Postdoctoral Fellow (CNS Gene Therapy)
1998-2002
Stony Brook University
PhD (Department of Biochemistry and Molecular Biology)
1991-1998
Colgate University
BA (Molecular Biology)
1985-1989
Marco Passini Skills
Biotechnology
Lifesciences
Molecular Biology
Biochemistry
Clinical Development
Gene Therapy
Genetics
Translational Research
In Vivo
High Throughput Screening
Transfection
Oncology
Neuroscience
Animal Models
RT-PCR
Immunology
Drug Discovery
DNA
Flow Cytometry
Tissue Culture
GLP
Fluorescence Microscopy
Monoclonal Antibodies
Virology
SDS-PAGE
Molecular Cloning
Customer Service
Strategic Planning
Management
Sds Page
Cell Biology
Rt Pcr
Marco Passini Summary
Marco Passini, based in Cambridge, MA, US, is currently a Biotechnology Consultant at Expertise in Gene and Oligonucleotide Therapies for CNS and Muscle Disorders. Marco Passini brings experience from previous roles at Korro Bio, Inc., Disarm Therapeutics, a wholly owned subsidiary of Eli Lilly, Sarepta Therapeutics and Genzyme Corporation, a Sanofi Company. Marco Passini holds a 1998 - 2002 Postdoctoral Fellow in CNS Gene Therapy @ University of Pennsylvania. With a robust skill set that includes Biotechnology, Lifesciences, Molecular Biology, Biochemistry, Clinical Development and more. Marco Passini has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Marco Passini?
Find contact details for 700 million professionals.